ID: ALA2381661

Max Phase: Preclinical

Molecular Formula: C37H56BN7O9

Molecular Weight: 753.71

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CCCCCN)C(=O)N[C@H](Cc1ccccc1)B(O)O

Standard InChI:  InChI=1S/C37H56BN7O9/c1-2-3-17-27(35(50)45-31(38(53)54)23-26-15-9-5-10-16-26)42-34(49)28(19-20-32(40)47)43-37(52)30(24-46)44-36(51)29(22-25-13-7-4-8-14-25)41-33(48)18-11-6-12-21-39/h4-5,7-10,13-16,27-31,46,53-54H,2-3,6,11-12,17-24,39H2,1H3,(H2,40,47)(H,41,48)(H,42,49)(H,43,52)(H,44,51)(H,45,50)/t27-,28-,29-,30-,31+/m0/s1

Standard InChI Key:  TXNGMIPLYYSXFQ-STVCLKQXSA-N

Associated Targets(Human)

Prostate specific antigen 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 753.71Molecular Weight (Monoisotopic): 753.4233AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Kostova MB, Rosen DM, Chen Y, Mease RC, Denmeade SR..  (2013)  Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.,  56  (11): [PMID:23692593] [10.1021/jm301718c]

Source